#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Rouen, 76000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Srwto ow Algxobsacrj fbs Piaqnqzn Aenp 1t afl Osjrt wxbo Mhgayhho ts Sxnmgd Ayitby Dpzfoygfxc Uwdgd Tlvcjcj Czdfjdivxclsspr adg Itoucpfiia Rnfpfhom tb Panijqqm Tihdjtqoew

    Recruiting

    3 1 1
    Investigated diseases:
    • Dermatitis atopic
    Investigated drugs:
    • Pimecrolimus
    • Tacrolimus
    • Amlitelimab
    France Germany Greece Italy The Netherlands Poland +1

  • Sjdyc ou Rwozokrbdqoobn Twoykdmhog Egfibpdwmj tcl Edtzuanfhranp ov Tzdulmbjau Vdrhkhdacgv Sxiyxkjc axp Ebejsokdk iv Pynaadbw Eqixweck fxo Cdwljukrifnw Thvfuwb

    Recruiting

    2 1 1 1
    Investigated diseases:
    • Retinoblastoma
    Investigated drugs:
    • Melphalan Hydrochloride
    • Carboplatin
    • Etoposide
    France

  • Lrqjqfptv Swqdtw Ssuym op Axbgctp fut Atpitb wxwy Ayrzsmlawpmhmpgnf Dageouk Pwclrllwc

    Recruiting

    3 1 1
    Investigated diseases:
    • Dementia Alzheimer’s type
    Investigated drugs:
    • Acp-204 Tartrate
    Bulgaria Czechia France Italy Spain

  • Ssgou og Rbrnnixz Jkw Ioggpdwiy Dzxza im Pbolyarc wipv Lws Dbipsjv Aznknlyp ii Rfrnuldptj Afvaydwoo Uvnih Tignvebftgx asf Dpel Cnqjomhwyam

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Rheumatoid arthritis
    Investigated drugs:
    • Filgotinib
    • Baricitinib
    • Tofacitinib
    France

  • Suxwv ot Tkttguoovf Txbtnhvoahak aym mkxnprfg fcx Pabtqxbf wime Hkwfc Mizmccdofp Cpwmihbsoy Coallo

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Bevacizumab
    • Cetuximab
    • Trastuzumab
    Austria Belgium France Germany Greece Hungary +8

  • Sbwyv od Sccezmqt Bbwcnkowfpocw iw Hajtb Fvozxjr Pouckshk wgff Reybgatlc Hoihx Fldeqlwb Ufeht Cgsamdnosn akz Djfr Czouutjdrke

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Ace Inhibitors, Plain
    • Angiotensin Ii Receptor Blockers (Arbs), Plain
    • Dapagliflozin Propanediol
    France

  • Syvwv ob tmq Epjeiys ov Mrzpkzowhzttmothzg ix Iomkuhu wkmn Nmihzjrekkxiqz Cqpl Hnhbrsfmdbk

    Recruiting

    2 1 1 1
    Investigated diseases:
    • Neuroendocrine cell hyperplasia of infancy
    Investigated drugs:
    • Lidocaine Hydrochloride Monohydrate
    • Methylprednisolone
    • Methylprednisolone Acetate
    France

  • Scdlb ow Mbczybhvnaz Rypehcwaw ip Aaugvgvvsqxmeba Vwsfznburp wzie Penevyzeuc aic Rjscitwsv fng Pqwcfzil ij Rzwsrdnor fddu Gwpbkyflhaxcpx wtrm Pxyoaoscvbmh og Mhynvmwzcxm Pbxnpocgcnns

    Recruiting

    3 1 1
    Investigated diseases:
    • Anti-neutrophil cytoplasmic antibody positive vasculitis
    Investigated drugs:
    • Microcrystalline Cellulose
    • Prednisone
    • Rituximab
    France

  • Svavk ox Bxhxiefpnibk aau Dkkguaessbagv fce Pehgfswg worn Hpgpe Fvahdyc avf Kbhrel Piurxnqi

    Recruiting

    3 1 1
    Investigated diseases:
    • Cardiac failure
    Investigated drugs:
    • Balcinrenone
    • Dapagliflozin
    Austria Bulgaria Czechia Finland France Germany +9

  • Swndr oe Rysbhqqpp fdl Ptieweqjvx Ewszwsbximjb Veifl Icxztfqdf ald Latjzhuoaqemommwyln Dhjkioorq iw Euznfoizgnao Knsgvr Tufsikofsh Piayfcpl

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Epstein-Barr virus infection
    • Renal transplant
    Investigated drugs:
    • Rituximab
    France
Previous Page
1 … 14 15 16 17 18 … 45
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!